Absolute Risk of Hepatocellular Carcinoma in a Large, Geographically and Ethnically Diverse Cohort of Patients with Non-Alcholic Fatty Liver Disease
Jennifer R. Kramer(Michael E. DeBakey VA Medical Center), Fasiha Kanwal(Michael E. DeBakey VA Medical Center), Aaron P. Thrift, Roxanne Desiderio, Xiaoying Yu(Baylor College of Medicine), Srikar Mapakshi(Michael E. DeBakey VA Medical Center), Hua Feng, Liang Li, Maneerat Chayanupatkul(Chulalongkorn University), Michael Lin, Hashem B. El‐Serag(Baylor College of Medicine)
Cited by 4
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020
|Gastroenterology|2022|1.2k
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
|Gastroenterology|2017|929
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
|Gastroenterology|2018|796